cartouche ECN WORKSHOP
-

Abstracts

Oral communications

1

2025 - Oral communication

Hyperuricemia and gout - treatment

Cost-effectiveness of nurse-led home monitoring of serum uric acid values for gout patients in secondary care: a modelling study

Jeffrey Van Der Ven, Msc; Marcel Flendrie, Md, Phd; Fenne Van Dijck; Maike Wientjes, Msc; Noortje Van Herwaarden, Md, Phd; Philip L Riches, Md, Phd; Bart J.f. Van Den Bemt, Prof., Phd; Lise M. Verhoef, Phd

2

2025 - Oral communication

Hyperuricemia and gout - treatment

Exploring Quality of Life Outcomes in Gout in Patients on a Treat-to-Target (TTT) Regime

Rowan Hart BMedSci (1), Amrey Krause PhD (2), Debbie Alexander BSc (1), Barbara Hauser PhD (1), Barbara Kuske PhD (1), Philip L Riches PhD (1)

4

2024 - Oral communication

Hyperuricemia and gout - treatment

“Gout remission” after 1-year of intensive urate-lowering with pegloticase

Yael Klionsky (1), Karina D Torralba (2), Katie Obermeyer (3), Lissa Padnick-Silver (3), Brian LaMoreaux (3), Gordon Lam (4)

Posters

5

2026 - Poster

Hyperuricemia and gout - treatment

Phenotyping renal and metabolic hyperuricemia: what BSA-corrected eGFR reveals

Janis Timsans, Raine Tiihonen, Jenni Kauppi, Vappu Rantalaiho, Anne Kerola, Kia Hakkarainen, Tiina Lehto, Hannu Kautiainen, Markku Kauppi

6

2026 - Poster

Hyperuricemia and gout - treatment

A Pragmatic Allopurinol Dose Escalation Strategy to Achieve Serum Urate Target inULT–Naïve Gout Patients: A Real-World Experience

Patricio Cardoso-Peñafiel [1,2], Maria Fernanda Del Pino-Zambrano [1,2], Marta Novella-Navarro [2,3], Clara Siso-Hernandez 1, Celia Sanchez-Jimenez 1, Carolina Marín-Huertas [1,4], Laura Cebrián-Méndez [1,4], Leticia Lojo-Oliveira [1,4], Ana Pareja-Martinez [1,4], Almudena , Roman-Pascual [1,4], Carmen Olga Sanchez Gonzalez [1,4], Isabel Fuente-Ruiz 5, Teresa Navio-Marco [1,4], Enrique Calvo-Aranda [1,2,4]

7

2026 - Poster

Hyperuricemia and gout - treatment

Serum urate during follow-up of gout is not associated to mortality in the lowest stratum

Ana M. Herrero-Beites (1)0, Nerea Perez-Herrero (2), Fernando Perez-Ruiz (3)

8

2026 - Poster

Hyperuricemia and gout - treatment

Acute kidney injury in gout: prevalence and risk factors through two decades

Nuria Perez-Herrero, Ana M. Herrero-Beites, Jose M. Urbizu-Gallardo, Fernando Perez-Ruiz

12

2026 - Poster

Hyperuricemia and gout - treatment

Analysis of allopurinol prescription suggests clinical inertia to increase doses

Fernando Perez-Ruiz*, Nerea Perez-Herrero**, Leire Marcos Fernandez***

13

2026 - Poster

Hyperuricemia and gout - treatment

Uric acid: a surprising protector of large joints? Lower incidence of large joint replacements among individuals with higher SUA

Janis Timsans, Raine Tiihonen, Jenni Kauppi, Vappu Rantalaiho, Anne Kerola, Kia Hakkarainen, Tiina Lehto, Hannu Kautiainen, Markku Kauppi

15

2025 - Poster

Hyperuricemia and gout - treatment

Gout characteristics, comorbidities and management in a long primary care database from Catalonia: the GotAP study.

Maria Antonia Pou, Carlen Reyes, Daniel Martinez-Laguna, Pau Satorra, Cristian Tebe, Nicola Dalbeth, Cesar Diaz-Torne

16

2025 - Poster

Hyperuricemia and gout - treatment

Identification of non-coding RNAs controlling gout-relevant genes

Nils Asmann (1), Nicholas A. Sumpter (1), Brenda Kischkel (1), Ezio T. Fok (2,3), Mumin Ozturk (2,3), Riku Takei (4), Megan P. Leask (6), Musa M. Mhlanga (2,3), Tony R. Merriman (4,5), Leo A. B. Joosten (1,7)

17

2026 - Poster

Hyperuricemia and gout - treatment

Understanding gout management patterns among primary care physicians: systematic literature review and analysis

Paul Doghramji, Richard Lai, Alexis Woods, Salvador Brito, Niranjan Kathe, Brian Lamoreaux

18

2025 - Poster

Hyperuricemia and gout - treatment

Comorbidity burden and health resource utilization in controlled vs. uncontrolled gout: A retrospective claims-based analysis

Richard Lai (1), Suneet Grewal (2), Kaiding Zhu (3), Stephani Gray (3), Andrea Meyers (3), Brian Lamoreaux (3)

19

2026 - Poster

Hyperuricemia and gout - treatment

Subcutaneous tocilizumab in difficulttotreat tophaceous gout refractory to anakinra: areal-world case series

MF Del Pino Zambrano , P Cardoso Peñafiel, C Marín Huertas, L Cebrián Méndez, L Lojo Oliveira, A Pareja Martinez, A Román Pascual, O Sánchez González, C Siso Hernández, S Cruz Beltran, Mt Navío Marco, E Calvo Aranda

20

2024 - Poster

Hyperuricemia and gout - treatment

The response of ultrasound and clinical features of gout in patients managed with a treat-to-target serum urate protocol

David Bursill (1,2), Anita Lee1,2, Kim Griggs (1,2), Phoebe Hunter (1,2), Emma Hocking (1,2), Leah McWilliams (1), Vidya Limaye (1,2), Susanna Proudman (1,2)